By: Beroe Inc. --
11 November, 2014
Innovation in drug delivery devices has reached new heights as primary packaging is identified by customers as a key product differentiator. Drug delivery device manufacturers are not only increasingly looking to other industries and smaller start-ups to identify novel technologies but stay competitive as well. Device developers are also coming up with new innovative products that are not only patient-friendly and cost effective but also innovative and functional. In such a scenario, device manufacturers would have to be prudent in identifying innovations that would strike a balance between offering patients additional functionalities and at the same time staying economical. Speakers: Swaminathan Narayanan: Swaminathan is a drug delivery devices expert at Beroe. He is a senior research analyst and specializes in providing drug delivery related procurement intelligence to Fortune 500 companies. Swaminathan has been an opinion leader at leading industry events such as Extractables & Leacheables conducted by Smither's Rapra. He has written and published papers in several leading medical device journals - including "Plastic Prefilled Syringes: Breaking the Barriers of Glass", "Impact of Medical Devices Tax and Proposed Way Out" and "Managing Leachables and Extractables - A Supply Chain Perspective". Ambuj Jain: Ambuj is currently the General Manager, India for Cambridge Consultants working closely with pharmaceutical companies for their drug delivery requirements. He has been associated with the Healthcare sector for more than 14 years with experience in Pharmaceutical, Medical Devices and Drug Delivery devices and is a B. Pharm and MBA by qualification. He has worked with companies such as Sanofi, Ranbaxy, Abbott, and Becton Dickinson in the past before moving on to set the operations of Cambridge Consultants in India 6 months ago.
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)